These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31771739)

  • 1. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
    Zhang S; Wang L; Lu F; Pei Y; Yang Y
    Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
    Wang L; Zhan C; Gu J; Xi J; Lin Z; Xue L; Ge D; Wang Q
    Clin Lung Cancer; 2019 May; 20(3):e346-e355. PubMed ID: 30665872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients 
Treated with Surgery].
    Yang H; Dai L; Li P; Shen L; Yan W; Fan M; Chen K
    Zhongguo Fei Ai Za Zhi; 2015 Aug; 18(8):505-11. PubMed ID: 26302348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
    Liu JW; Li J; Lin G; Shang XQ
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analyses of risk factors for postoperative recurrence after curative resection of stage III A-N2 non-small cell lung cancer].
    Qiang G; Guo Y; Xiao F; Yu Q; Liang C; Song Z; Tian Y; Shi B; Liu D
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(41):3239-43. PubMed ID: 25604225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
    Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
    Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic Factors of N2 Stage Non-small Cell Lung Cancer after Surgery].
    Yang Z; Wei S; Xia L; Liu L
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):15-20. PubMed ID: 31948533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Patients with Stage III-N2 Non-small Cell Lung Cancer.
    Liu J; Shi Z; Cao B; Wang Z; Zhang N; Liu J
    Ann Surg Oncol; 2024 Aug; 31(8):5028-5037. PubMed ID: 38520577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.